• Something wrong with this record ?

HPLC-ESI-HRMS2 Determination of N-(2-Hydroxyethyl)-l-valyl-l-leucine in Human Urine: Method Validation

I. Hanzlíková, J. Mráz, M. Tvrdíková, H. Chrástecká, A. Moulisová, I. Linhart

. 2023 ; 47 (1) : 43-51. [pub] 2023Feb21

Language English Country England, Great Britain

Document type Journal Article

Biomonitoring of human exposure to reactive electrophilic chemicals such as ethylene oxide (EO) has been commonly based on the determination of adducts with N-terminal valine in blood protein globin, but a systematic search has also been undertaken to find surrogate markers enabling non-invasive sampling. Recently, N-(2-hydroxyethyl)-L-valyl-L-leucine (HEVL) has been identified as an ultimate cleavage product of EO-adducted globin in the urine of occupationally exposed workers. Herein, full validation of the analytical procedure consisting of solid-phase extraction of HEVL from urine samples (2 mL) followed by high-performance liquid chromatography-electrospray ionization-high-resolution mass spectrometry determination using deuterium-labeled HEVL as an internal standard (IS) is described. Method limit of quantitation is 0.25 ng/mL, and its selectivity is excellent as demonstrated by the invariable ratio of the qualifier and quantifier ion intensities across diverse urine samples and synthetic standard. The linear calibration model was applicable over the whole concentration range tested (0.25-10 ng/mL). The method accuracy assessed as a recovery of HEVL using a spiking experiment was 98-100%. Within-day precision of the method ranged from 1.8% to 3.0%, while the results from consecutive analytical runs conducted within 1 week or within 10-150 weeks differed in the range of 2.2-9.7%. The stability study on urine samples (-20°C up to 3 years, freeze-and-thaw up to 10 cycles) as well as on aqueous solutions (5°C up to 4 months) indicated no relevant changes in HEVL concentration (≤4%) over the time tested. Analytical responses of both HEVL and IS correlated with urinary creatinine as an index of matrix composition, but this matrix effect was mostly eliminated using the HEVL/IS peak area ratio, attaining the IS-normalized relative matrix effect <3%. In conclusion, the method complied successfully with the bioanalytical method validation criteria, making it a reliable tool for HEVL determination in human biomonitoring.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc23004133
003      
CZ-PrNML
005      
20230425141120.0
007      
ta
008      
230418s2023 enk f 000 0|eng||
009      
AR
024    7_
$a 10.1093/jat/bkac022 $2 doi
035    __
$a (PubMed)35388429
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a enk
100    1_
$a Hanzlíková, Iveta $u Centre of Occupational Health, National Institute of Public Health, Šrobárova 49/48, Prague 100 00, Czech Republic
245    10
$a HPLC-ESI-HRMS2 Determination of N-(2-Hydroxyethyl)-l-valyl-l-leucine in Human Urine: Method Validation / $c I. Hanzlíková, J. Mráz, M. Tvrdíková, H. Chrástecká, A. Moulisová, I. Linhart
520    9_
$a Biomonitoring of human exposure to reactive electrophilic chemicals such as ethylene oxide (EO) has been commonly based on the determination of adducts with N-terminal valine in blood protein globin, but a systematic search has also been undertaken to find surrogate markers enabling non-invasive sampling. Recently, N-(2-hydroxyethyl)-L-valyl-L-leucine (HEVL) has been identified as an ultimate cleavage product of EO-adducted globin in the urine of occupationally exposed workers. Herein, full validation of the analytical procedure consisting of solid-phase extraction of HEVL from urine samples (2 mL) followed by high-performance liquid chromatography-electrospray ionization-high-resolution mass spectrometry determination using deuterium-labeled HEVL as an internal standard (IS) is described. Method limit of quantitation is 0.25 ng/mL, and its selectivity is excellent as demonstrated by the invariable ratio of the qualifier and quantifier ion intensities across diverse urine samples and synthetic standard. The linear calibration model was applicable over the whole concentration range tested (0.25-10 ng/mL). The method accuracy assessed as a recovery of HEVL using a spiking experiment was 98-100%. Within-day precision of the method ranged from 1.8% to 3.0%, while the results from consecutive analytical runs conducted within 1 week or within 10-150 weeks differed in the range of 2.2-9.7%. The stability study on urine samples (-20°C up to 3 years, freeze-and-thaw up to 10 cycles) as well as on aqueous solutions (5°C up to 4 months) indicated no relevant changes in HEVL concentration (≤4%) over the time tested. Analytical responses of both HEVL and IS correlated with urinary creatinine as an index of matrix composition, but this matrix effect was mostly eliminated using the HEVL/IS peak area ratio, attaining the IS-normalized relative matrix effect <3%. In conclusion, the method complied successfully with the bioanalytical method validation criteria, making it a reliable tool for HEVL determination in human biomonitoring.
650    _2
$a lidé $7 D006801
650    _2
$a vysokoúčinná kapalinová chromatografie $7 D002851
650    _2
$a leucin $7 D007930
650    12
$a dipeptidy $7 D004151
650    12
$a ethylenoxid $7 D005027
650    _2
$a globiny $7 D005914
650    _2
$a reprodukovatelnost výsledků $7 D015203
655    _2
$a časopisecké články $7 D016428
700    1_
$a Mráz, Jaroslav $u Centre of Occupational Health, National Institute of Public Health, Šrobárova 49/48, Prague 100 00, Czech Republic $1 https://orcid.org/0000000299845593
700    1_
$a Tvrdíková, Monika $u Centre of Occupational Health, National Institute of Public Health, Šrobárova 49/48, Prague 100 00, Czech Republic
700    1_
$a Chrástecká, Hana $u Centre of Occupational Health, National Institute of Public Health, Šrobárova 49/48, Prague 100 00, Czech Republic
700    1_
$a Moulisová, Alena $u Centre of Toxicology and Health Safety, National Institute of Public Health, Šrobárova 49/48, Prague 100 00, Czech Republic $1 https://orcid.org/0000000255572562
700    1_
$a Linhart, Igor $u Department of Organic Chemistry, Faculty of Chemical Technology, University of Chemistry and Technology Prague, Technická 1905, Prague 166 28, Czech Republic
773    0_
$w MED00002510 $t Journal of analytical toxicology $x 1945-2403 $g Roč. 47, č. 1 (2023), s. 43-51
856    41
$u https://pubmed.ncbi.nlm.nih.gov/35388429 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20230418 $b ABA008
991    __
$a 20230425141116 $b ABA008
999    __
$a ok $b bmc $g 1924663 $s 1190342
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2023 $b 47 $c 1 $d 43-51 $e 2023Feb21 $i 1945-2403 $m Journal of analytical toxicology $n J Anal Toxicol $x MED00002510
LZP    __
$a Pubmed-20230418

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...